Copeland Capital Management LLC Has $286,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Copeland Capital Management LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 98.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 829 shares of the healthcare conglomerate’s stock after selling 40,266 shares during the period. Copeland Capital Management LLC’s holdings in UnitedHealth Group were worth $286,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of UNH. Fort Washington Investment Advisors Inc. OH lifted its holdings in UnitedHealth Group by 1.6% during the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 465,048 shares of the healthcare conglomerate’s stock worth $160,581,000 after buying an additional 7,329 shares during the period. Constitution Capital LLC lifted its stake in shares of UnitedHealth Group by 46.6% in the third quarter. Constitution Capital LLC now owns 9,827 shares of the healthcare conglomerate’s stock worth $3,393,000 after acquiring an additional 3,125 shares during the period. Bretton Capital Management LLC increased its position in UnitedHealth Group by 29.9% during the 3rd quarter. Bretton Capital Management LLC now owns 21,700 shares of the healthcare conglomerate’s stock valued at $7,493,000 after purchasing an additional 5,000 shares during the period. Ullmann Wealth Partners Group LLC lifted its position in shares of UnitedHealth Group by 22.4% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,180 shares of the healthcare conglomerate’s stock worth $408,000 after purchasing an additional 216 shares during the period. Finally, Ethic Inc. increased its position in shares of UnitedHealth Group by 0.3% during the third quarter. Ethic Inc. now owns 91,552 shares of the healthcare conglomerate’s stock worth $31,613,000 after buying an additional 263 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 1.0%

Shares of NYSE UNH opened at $332.13 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a market capitalization of $300.86 billion, a P/E ratio of 17.33, a P/E/G ratio of 2.14 and a beta of 0.43. The company has a 50-day moving average price of $332.33 and a 200-day moving average price of $319.37.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.15 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. TD Cowen increased their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Barclays lifted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Finally, JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.